Cellebrite DI (NASDAQ:CLBT) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research note released on Friday,Benzinga reports. They currently have a $28.00 price target on the stock. CLBT has been the subject of several other reports. Craig Hallum upped their price target on shares of Cellebrite DI […]
Needham & Company LLC reissued their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research note released on Friday,Benzinga reports. They currently have a $28.00 price target on the stock. CLBT has been the subject of several other reports. Craig Hallum upped their price target on shares of Cellebrite DI […]
